Blaze Medical Devices

Blaze Medical Devices has developed technology that enables comprehensive and standardized assessment of blood damage, particularly to red blood cells (RBCs). The company's main product lines include the RBC Mechanical Fragmentation Measurement System for testing mechanical fragility (MF) of RBCs and the RBC Hemolysis Testing System, which also incorporates fragmentation measurement capabilities. Initial models of these systems are suitable for a wide range of industrial R&D and other research applications, while subsequent product lines will target medical applications.